AstraZeneca (AstraZeneca) Days Sales Outstanding

: 74.78 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

AstraZeneca's average Accounts Receivable for the three months ended in Dec. 2023 was $9,854 Mil. AstraZeneca's Revenue for the three months ended in Dec. 2023 was $12,024 Mil. Hence, AstraZeneca's Days Sales Outstanding for the three months ended in Dec. 2023 was 74.78.

The historical rank and industry rank for AstraZeneca's Days Sales Outstanding or its related term are showing as below:

AZN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 45.29 Med: 51.23 Max: 77.3
Current: 77.3

During the past 13 years, AstraZeneca's highest Days Sales Outstanding was 77.30. The lowest was 45.29. And the median was 51.23.

AZN's Days Sales Outstanding is ranked worse than
55.74% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.07 vs AZN: 77.30

AstraZeneca's Days Sales Outstanding increased from Dec. 2022 (67.37) to Dec. 2023 (74.78).

AstraZeneca Days Sales Outstanding Historical Data

The historical data trend for AstraZeneca's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

49.25

50.68

47.98

54.49

62.22

AstraZeneca Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																67.37	73.40	85.45	88.90	74.78

Competitive Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Days Sales Outstanding falls into.

AstraZeneca Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

AstraZeneca's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (7212	+	8407)	/	2 )	/	45811	*	365
=	7809.5					/	45811	*	365
=	62.22

AstraZeneca's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (11300	+	8407)	/	2 )	/	12024	*	365 / 4
=	9853.5					/	12024	*	365 / 4
=	74.78

AstraZeneca (NAS:AZN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

AstraZeneca Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.